CD4 and diabetes mellitus: We previously focused on Zbtb32 as a potential regulator of T cell tolerance in the NOD mouse model, and found that this transcription regulator was preferentially induced in autoreactive CD4+ T cells after interacting with tolerogenic DCIR2+ DCs, and that overexpression in T cells inhibited both diabetes and effector T cell expansion6.